Q2 2026 featured low Balama production and a transition to commercial AAM at Vidalia, with a US$98m cash balance and improved operating cash flow. Strategic funding and US policy support are key to future ramp-ups and market positioning.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.